In 2024, the U.S. Drug Enforcement Administration (DEA) indicated which they plan to reclassify cannabis being a Timetable III drug. This rescheduling will acknowledge that cannabis has legitimate clinical needs and might help open up the door to investigate on other potential procedure works by using. Cómo ayudar a alguien https://traffic-accident-claims23232.blogdon.net/a-review-of-mind-altering-cannabis-compounds-51268497